Stockreport

Dermata Therapeutics, Inc. Announces Closing of Upsized $18.0 Million Initial Public Offering

Dermata Therapeutics, Inc.  (DRMA) 
PDF SAN DIEGO, CA / ACCESSWIRE / August 17, 2021 / Dermata Therapeutics, Inc. ("Dermata" or the "Company") (NASDAQ:DRMA, DRMAW), a clinical-stage medical dermatology company [Read more]